JPRN-UMIN000030909招募中1 期
Phase I/II trial of combined chemotherapy of Nab-paclitaxel, S-1, and Oxaliplatin for gastric cancer patients with peritoneal metastasis (NSOX study) - NSOX study
Wakayama Medical University, School of Medicine0 个研究点目标入组 35 人开始时间: 2018年1月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. History of hypersensitivity to nab-paclitaxel, S-1, oxaliplatin 2. Contraindication to nab-paclitaxel, S-1, oxaliplatin 3. Infectious disease 4. HBs-antigen positive 5. Severe complication 6. Neuropathy with symptoms 7. Brain metastasis with clinical symptoms 8. Watery diarrhea. 9. Active double cancer 10. Persons to be pregnant or to make pregnant 11. Any subject judged by the investigator to be unfit for any reason to participate in the study
研究者
相似试验
已完成
1 期
Phase I study of combination chemotherapy with nab-paclitaxel and Nedaplatin as first-line treatment in patients with advanced squamous cell lung cancer.Squamous cell lung cancerJPRN-UMIN000010963Kitasato University School of Medicine Department of Respiratory Medicine16
招募中
2 期
Phase II study of combination chemotherapy using paclitaxel, carboplatin, and bevacizumab in patients with advanced or recurrent cervical cancer.cervical cancerJPRN-UMIN000024137Hyogo Cancer Center30
招募中
1 期
Phase I/II trial of combination chemotherapy using TS-1, CPT-11 and cetuximab with radiation in locally advanced rectal cancerRectal cancerJPRN-UMIN000002602Yokohama City University Graduate School of Medicine35
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
1 期
Phase I trial of combined chemotherapy of bevacizumab, panitumumab and irinotecan as 3rd-line chemotherapy in chmotherapy-refractory metastatic colorectal cancer.Colorectal cancerJPRN-UMIN000009362ational Cancer Center Hospital, Tokyo, Japan.12